HSBC Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Buy
+31,175
New +$207K ﹤0.01% 2636
2025
Q2
Sell
-16,205
Closed -$88K 3269
2025
Q1
$88K Sell
16,205
-107
-0.7% -$432 ﹤0.01% 2835
2024
Q4
$55.5K Sell
16,312
-7,349
-31% -$23.6K ﹤0.01% 2973
2024
Q3
$67.3K Sell
23,661
-315
-1% -$809 ﹤0.01% 2855
2024
Q2
$53.5K Sell
23,976
-1,084
-4% -$2.19K ﹤0.01% 2810
2024
Q1
$55.4K Buy
25,060
+14,444
+136% +$37.4K ﹤0.01% 2929
2023
Q4
$25.2K Hold
10,616
﹤0.01% 2679
2023
Q3
$19.8K Hold
10,616
﹤0.01% 2673
2023
Q2
$27.5K Hold
10,616
﹤0.01% 2510
2023
Q1
$17.2K Hold
10,616
﹤0.01% 2613
2022
Q4
$13.5K Hold
10,616
﹤0.01% 3026
2022
Q3
$17K Hold
10,616
﹤0.01% 2877
2022
Q2
$16K Sell
10,616
-2,474
-19% -$5.22K ﹤0.01% 3203
2022
Q1
$34K Sell
13,090
-1,302
-9% -$3.18K ﹤0.01% 3217
2021
Q4
$42K Sell
14,392
-827
-5% -$1.79K ﹤0.01% 3212
2021
Q3
$37K Buy
+15,219
New +$44.2K ﹤0.01% 2940

Other funds holding XERS